Most of the groundbreaking work in the treatment of chronic inflammatory diseases has focused on the treatment of the chronic condition.  Even with the available treatments and the promising new treatments such as MP8, patients often suffer from acute flare-ups, where joints become inflamed and cause pain and immobility. 

Here at Meyer, we are working on several novel treatments for these acute flare-ups.  These treatments are injected directly into the intra-articular space of arthritic joints.  One promising compound, MP30, is in early pre-clinical testing.